These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6065595)

  • 21. [Therapy results with nalidixic acid in chronic urinary tract infection].
    Broghammer H
    Arzneimittelforschung; 1968 Sep; 18(9):1139-43. PubMed ID: 4885373
    [No Abstract]   [Full Text] [Related]  

  • 22. [Frequency of isolation and antibiotic sensitivity of strains of coli bacilli from urinary tract infections isolated in private laboratories].
    Bourlioux P; Bourlioux N; Bournaud M
    Pathol Biol (Paris); 1983 Jun; 31(6):536-9. PubMed ID: 6348665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of laboratory data in the choice of antibiotics for the treatment of infections caused by microbes of the genus Proteus].
    Kuznetsova SM; Fomina IP
    Antibiotiki; 1969 May; 14(5):422-6. PubMed ID: 4891716
    [No Abstract]   [Full Text] [Related]  

  • 24. [Urinary tract infections due to Proteus rettgeri].
    Bauernfeind A
    Fortschr Med; 1973 May; 91(13):588. PubMed ID: 4701128
    [No Abstract]   [Full Text] [Related]  

  • 25. Transferable antibiotic resistance in enterobacteriaceae isolated from urinary tract infections in general practice.
    Poston SM; Maclaren DM; Thornton VG
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):326-33. PubMed ID: 352037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Penicillinase-forming gram-negative bacilli as etiologic factor of urologic infections].
    Bobrovskiĭ M; Dzerzhanovskaia D; Filipchuk Ia
    Antibiotiki; 1970 Feb; 15(2):102-7. PubMed ID: 4913954
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current analysis of pathogen spectrum and resistance in bacterial urinary tract infections. Bacteriologic urine findings of hospitalized urologic patients].
    Osterhage HR; Grups JW; Ackermann R; Frohmüller H
    Fortschr Med; 1984 Dec; 102(46):1178-80. PubMed ID: 6394458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Ravagnan G
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1644-7. PubMed ID: 3435110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug resistance of bacterial flora in the urine of patients with urologic diseases].
    Sukhodol'skaia AE; Chaĭkovskaia VL
    Sov Med; 1972 Mar; 35(3):107-10. PubMed ID: 5018153
    [No Abstract]   [Full Text] [Related]  

  • 30. [On the incidence of Proteus in diseases of children. Sensitivity to antibiotics].
    Zalman MW; Drăgan I; Silaghi C
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):569-76. PubMed ID: 5400048
    [No Abstract]   [Full Text] [Related]  

  • 31. [Septicemia in urology; the viewpoint of the bacteriologist].
    Peloux Y
    J Urol Nephrol (Paris); 1976; 82 Suppl 2():161-5. PubMed ID: 1031696
    [No Abstract]   [Full Text] [Related]  

  • 32. [Frequency and antibiotic susceptibility of bacteria responsible for urinary infections in private practice from 1986 to 1990. Results of 5398 samples].
    de Moüy D
    Pathol Biol (Paris); 1991 May; 39(5):495-9. PubMed ID: 1881681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
    Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
    Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of urinary tract infections: striking Gram-negative germs. Changes in the bacterial spectrum and resistance in a group of patients over an 18-year period].
    Gussmann S
    Fortschr Med; 1983 Sep; 101(36):1626-9. PubMed ID: 6629294
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the therapy of spontaneous and antibiotic-induced simple and multiple changes in the causative agents of urinary tract infection as well as the therapy of the resistance of these agents to antibiotics].
    Chwalla R
    Z Urol Nephrol; 1965 Jun; 58(6):375-80. PubMed ID: 4953703
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bacterial agents responsible for urinary tract infections. III. A clinico-statistical contribution].
    Roscioni C; Pennelli GM; Monaco G; Roscioni MC
    Clin Ter; 1988 Aug; 126(3):207-15. PubMed ID: 2974387
    [No Abstract]   [Full Text] [Related]  

  • 37. Urinary tract infection and drug-resistant bacteria in different patient populations.
    Nitzan Y; Maayan M; Wajsman C; Drucker M
    Isr J Med Sci; 1983 Dec; 19(12):1039-45. PubMed ID: 6363352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nosocomial multiply resistant Providencia stuartii: a long-term outbreak with multiple biotypes and serotypes at one hospital.
    Kocka FE; Srinivasan S; Mowjood M; Kantor HS
    J Clin Microbiol; 1980 Feb; 11(2):167-9. PubMed ID: 7358840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary tract infection with proteus species in a teaching hospital.
    Ozumba UC; Dosunmi-Ogunbi O; Onile B
    East Afr Med J; 1995 Jan; 72(1):72-4. PubMed ID: 7781563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. R-factors in urinary tract infection.
    Harkness JL; Anderson FM; Datta N
    Kidney Int Suppl; 1975 Aug; 4():S130-3. PubMed ID: 1104976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.